Using the BTS CAP audit to evaluate local data
- B Singh1,
- D G Wootton1,
- J Brown2,
- B Chakrabarti2,
- R P D Cooke3,
- S B Gordon4 on behalf of the University Hospital Aintree Pneumonia Group
- 1Respiratory Research, University Hospital Aintree, Liverpool, UK
- 2Department of Thoracic Medicine, University Hospital Aintree, Liverpool, UK
- 3Department of Microbiology, University Hospital Aintree, Liverpool, UK
- 4Respiratory Infection, Liverpool School of Tropical Medicine, Liverpool, UK
- Correspondence to Dr Biswajit Chakrabarti, Thoracic Medicine, Aintree University Hospital, Liverpool L9 7AL, UK; biswajit.chakrabarti{at}aintree.nhs.uk
-
Contributors All authors have read and approved the letter.
- Accepted 25 August 2011
- Published Online First 20 September 2011
- Aspergillus lung disease
- asthma
- non-invasive ventilation
- palliative care
- pneumonia
- respiratory infection
- sleep apnoea
- tuberculosis
- bacterial infection
- innate immunity
- macrophage biology
- viral infection
- pleural disease
- asthma mechanisms
- COPD exacerbations
- COPD mechanisms
- cough/mechanisms/pharmacology
We read Dr Lim and Dr Woodhead's update on the British Thoracic Society (BTS) 2009/2010 community acquired pneumonia (CAP) audit with interest and noted the high inpatient mortality rate of 18.3%.1 As a contributing site, we received a useful summary of our data in comparison with the national data and local mortality rates for severe CAP (CURB65 3-5) were 21.4% versus 42.6% nationally. This provoked an examination of local severe CAP admissions between December 2009 and …
